Drug profile · INN
indacaterol + glycopyrronium + mometasone
ENERZAIR BREEZHALER
indacaterol + glycopyrronium + mometasone (ENERZAIR BREEZHALER) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — indacaterol + glycopyrronium + mometasone
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
indacaterol + glycopyrronium + mometasone (ENERZAIR BREEZHALER) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
Key facts
INN indacaterol + glycopyrronium + mometasone
Brand ENERZAIR BREEZHALER
Originator Novartis Pharmaceuticals
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is indacaterol + glycopyrronium + mometasone?
indacaterol + glycopyrronium + mometasone (ENERZAIR BREEZHALER) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
What is the brand name for indacaterol + glycopyrronium + mometasone?
ENERZAIR BREEZHALER is a marketed brand name for indacaterol + glycopyrronium + mometasone. Check FDA Drugs@FDA for the current US label holder and prescribing information.